Psychopathology, psychopharmacology and the organic brain syndromes.
D000662:Amphetamines / Q000627:therapeutic use; D014151:Anti-Anxiety Agents / Q000627:therapeutic use; D000925:Anticoagulants / Q000627:therapeutic use; D000928:Antidepressive Agents / Q000627:therapeutic use; D014150:Antipsychotic Agents / Q000627:therapeutic use; D002560:Cerebrovascular Circulation / Q000187:drug effects; D003704:Dementia / Q000188:drug therapy; D005260:Female; D006728:Hormones / Q000627:therapeutic use; D006801:Humans; D006993:Hypnotics and Sedatives / Q000627:therapeutic use; D008297:Male; D008568:Memory / Q000187:drug effects; D019965:Neurocognitive Disorders / Q000188:drug therapy*; D010389:Pemoline / Q000627:therapeutic use; D011619:Psychotropic Drugs / Q000627:therapeutic use*; D012313:RNA / Q000627:therapeutic use; D014665:Vasodilator Agents / Q000627:therapeutic use; D014815:Vitamins / Q000627:therapeutic use
D000662:Amphetamines; D014151:Anti-Anxiety Agents; D000925:Anticoagulants; D000928:Antidepressive Agents; D014150:Antipsychotic Agents; D006728:Hormones; D006993:Hypnotics and Sedatives; D011619:Psychotropic Drugs; D014665:Vasodilator Agents; D014815:Vitamins; D012313:RNA; D010389:Pemoline